UK Markets closed

BRAIN Biotech AG (0RFI.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
5.66-0.30 (-5.03%)
At close: 12:42PM BST
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.38
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 35.71
52-week low 35.66
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 518.06M
Implied shares outstanding 6N/A
Float 810.09M
% held by insiders 157.43%
% held by institutions 128.75%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Sept 2022
Most-recent quarter (mrq)30 Sept 2022


Profit margin -13.10%
Operating margin (ttm)-12.69%

Management effectiveness

Return on assets (ttm)-5.12%
Return on equity (ttm)-16.67%

Income statement

Revenue (ttm)50.3M
Revenue per share (ttm)2.30
Quarterly revenue growth (yoy)25.30%
Gross profit (ttm)27.61M
Net income avi to common (ttm)-6.59M
Diluted EPS (ttm)-0.58
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)8.53M
Total cash per share (mrq)0.39
Total debt (mrq)10.74M
Total debt/equity (mrq)31.36
Current ratio (mrq)1.42
Book value per share (mrq)1.28

Cash flow statement

Operating cash flow (ttm)-1.49M
Levered free cash flow (ttm)-2.36M